BIOTEST ApS: Financial statements 2024
CVR: 26736994
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOTEST ApS (CVR 26736994) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 12,978 and a net result of DKK 100,748 compared with DKK 240,932 the year before. Equity in the 2024 report amounted to DKK 1,235,666. The solvency ratio was 90.4%.
- Gross Profit
- DKK 12,978
- Profit/Loss
- DKK 100,748
- Equity
- DKK 1,235,666
- Total Assets
- DKK 1,366,911
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 13 t. | 101 t. | 1.2 mio. | - |
| 2023 | - | -38 t. | 241 t. | 1.3 mio. | - |
| 2022 | - | -36 t. | -391 t. | 1 mio. | 1 |
| 2021 | - | 272 t. | 127 t. | 1.5 mio. | 1 |
| 2020 | - | 399 t. | 280 t. | 1.5 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BIOTEST ApS has published its annual report for 2023. Gross profit came to DKK -37,742, and the net result was DKK 240,932.
About BIOTEST ApS
BIOTEST ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2002. The company is registered under the industry Anden måling og teknisk analyse. The management consists of Pauli Lejf Kiel. The company is owned by Pauli Lejf Kiel. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -54,968 and a net result of DKK -65,376 compared with DKK 100,748 the year before. Equity in the 2025 report amounted to DKK 1,035,290.